New Weight Loss Pill Amycretin vs. Weight Loss Injection Wegovy
An early trial suggests that a pill made by the firm behind Ozempic may be twice as effective as the fat jab in weight loss. The pill, called amycretin, led to a 13% body weight loss in 12 weeks compared to 6% from the jab Wegovy. The pharmaceutical firm Novo Nordisk's value surged on the results, making it more valuable than Elon Musk's Tesla. Demand for the pill is high due to its potential effectiveness in treating obesity and related health conditions.